Lifespin GmbH and Acıbadem forge ‘Metabolomics’ partnership to advance personalised medicine

image credit- shutterstock

Germany-headquartered Lifespin GmbH, a pioneer in health status detection software, has teamed up with Turkey-based Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revolutionszing personalized healthcare. This collaboration is set to develop and expand the global market for innovative healthcare solutions that utilise a combination of advanced Nuclear Magnetic Resonance (NMR) and artificial intelligence (AI) technologies.

Under the agreement, Lifespin GmbH and ACU will combine their expertise to establish a state-of-the-art, AI-enabled, NMR-based metabolomics precision medicine platform. This joint venture will focus on deploying Lifespin's cutting-edge products across ACU's extensive network through a Software-as-a-service (SaaS) model, offering these technologies at competitive rates.

The partnership's mission extends beyond improving patient care across Eurasia; it ambitiously targets expansion into Africa and the Arabian Peninsula, with Istanbul positioned as the central hub. In addition to commercial endeavors, Lifespin, and Acıbadem University are eager to explore opportunities for joint development of new healthcare solutions as well as the digitalization of ACU's extensive biobank. The agreement also encompasses the creation of a Regional Data Analysis and Data Production Center Laboratory, which will support the development and distribution of Lifespin's products globally.